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Abstract: Since sponges, as typical filter-feeders, are exposed to a high load of attacking 
prokaryotic and eukaryotic organisms, they are armed with a wide arsenal of 
antimicrobial/cytostatic low-molecular-weight, non-proteinaceous bioactive compounds. 
Here we present the first sponge agent belonging to the group of ASABF-type 
antimicrobial peptides. The ASABF gene was identified and cloned from the demosponge 
Suberites domuncula. The mature peptide, with a length of 64 aa residues has a predicted 
pI of 9.24, and comprises the characteristic CSαβ structural motif. Consequently, the   
S. domuncula ASABF shares high similarity with the nematode ASABFs; it is distantly 
related to the defensins. The recombinant peptide was found to display besides 
microbicidal activity, anti-fungal activity. In addition, the peptide lyses human 
erythrocytes. The expression of ASABF is upregulated after exposure to the apoptosis-
inducing agent 2,2'-dipyridyl. During the process of apoptosis of surface tissue of S. 
domuncula, grazing gastropods (Bittium sp.) are attracted by quinolinic acid which is 
synthesized through the kynurenine pathway by the enzyme 3-hydroxyanthranilate   
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3,4-dioxygenase (HAD). Finally, the gastropods are repelled from the sponge tissue by the 
ASABF. It is shown that the effector peptide ASABF is sequentially expressed after the 
induction of the HAD gene and a caspase, as a central enzyme executing apoptosis.  
Keywords: sponges; Suberites domuncula; ASABF; antimicrobial peptides; apoptosis; 
Bittium sp. 
 
1. Introduction 
Sponges, as sessile filter feeders, are exposed to a huge number of microorganisms, including 
bacteria, fungi, and viruses, which are eliminated during the passage through the aquiferous sponge 
canal system [1]. It had been calculated that some sponge species filter up to 0.84 cm
3 of water per 
second per cubic centimeter of sponge tissue through their canals to extract edible material [2]. In 
order to resist against those microorganisms that could be harmful for the sponge specimens, these 
animals have developed a wide array of bioactive compounds [3] that act highly specifically and 
efficiently. Among those are secondary metabolites interfering with distinct pathways of higher 
metazoans, such as tyrosine kinases (e.g., aeroplysinin), and replication of viruses, e.g., herpes simplex 
viruses (arabinofuranosyl adenine) or retroviruses (e.g., avarol) [4,5].  
In addition to those directly acting inhibitory, secondary metabolites sponges have a very effective 
immune system [6]. Nevertheless it is well established that sponges are not provided with an   
antigen-specific adaptive immune system, even though they express proteins composed of two 
characteristic immunoglobulin (Ig)-like domains, e.g., in Geodia cydonium [7]. However, these 
animals compensate this lack with a highly diverse innate immune system against non-specific as well 
as specific targets [8]. Most of the biological and molecular biological studies on immune responses in 
sponges have been performed with the demosponge Suberites domuncula. For example, fungi are 
recognized by specific D-glucan carbohydrate receptors [9] and subsequently eliminated by expression 
of a fibrinogen-like protein. Gram-positive bacteria are killed by an increased induction of lysozyme [10], 
resulting in lysis of the microorganisms and subsequent phagocytosis. Gram-negative bacteria are 
recognized by sponges through a lipopolysaccharide-interacting protein and eliminated by expression 
of perforins through activation of a MyD88-dependent signaling pathway [11]. It should be noted that 
most of the recognition and effector molecules display high sequence similarities to polypeptides 
identified in deuterostomians. However, sponges also produce molecules that are only found in some 
protostomian taxa, e.g., a GlcNAc/GalNAc-binding lectin (tachylectin; [12]). It is amazing that this 
rich arsenal exists in the phylum Porifera which is the oldest, still extant, animal phylum, originating 
from the common metazoan ancestor, the Urmetazoa [13].  
Considering the large and diverse number of noxious prokaryotic and eukaryotic organisms passing 
through sponges, it appeared to be compelling to search for antimicrobial peptides displaying broad 
activity spectra. It is well established that cationic antimicrobial peptides are produced by higher 
metazoans as host defense against microorganisms [14]. Recently they have been recognized as 
promising novel antimicrobial and antitumor agents [15]. The defensins and the ASABF (Ascaris suum 
antibacterial factor) are grouped to those peptides [16]. By screening the S. domuncula database that Mar. Drugs 2011, 9                                                  
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comprises over 40,000 sequences [17] several ESTs (Expressed Sequence Tag) were identified that 
displayed defensin-like sequence similarity. More specifically, the deduced protein shared highest 
relationship with the antimicrobial peptide designated as ASABF. ASABF peptides were first 
identified in Ascaris suum [18] and subsequently also in Caenorhabditis elegans [19]. The ASABF 
peptides and the defensins are both cysteine-rich. While the defensins are widespread both in 
protostomians and in deuterostomians [20], the ASABF peptides are restricted, among the triploblastic 
animals, to the nematodes [21]. In contrast to the defensins which comprise two to three antiparallel  
β-sheets that are linked together by three to four intramolecular disulfide bridges, the characteristic 
ASABFs have eight cysteine residues that form four disulfide bridges [22]. In the present study we 
report on the first sponge cDNA encoding an ASABF peptide. The predicted, mature peptide from  
S. domuncula, comprising 64 aa (amino acid) residues, was shown to be cationic (isoelectric point >8), 
a characteristic that it shares with the other known ASABFs [23]. Furthermore, we also checked the 
database from the Baikalian freshwater sponge Lubomirskia baicalensis for the existence of an 
ASABF-encoding cDNA; a cDNA fragment was found and completed. However, this sequence shared 
only little sequence similarity with other ASABFs or defensins.  
The recombinant sponge ASABF protein was shown to be biologically active, as microbicidal (as 
expected) peptide possessing also hemolytic activity. Furthermore, we report here for the first time that 
an ASABF peptide is toxic also for metazoans. It is shown that the ASABF peptide was toxic for the 
marine gastropod/molluscs Bittium sp. which settled on apoptotic patches on the sponge surface [24]. 
The gastropod was attracted by the sponge after induction of the 3-hydroxyanthranilate  
3,4-dioxygenase (HAD) gene, through quinolinic acid, a metabolite of the kynurenine pathway. In 
parallel with the increase in the steady-state level of HAD, the expression of a gene encoding a caspase 
was induced [25] that is known to be one key enzyme induced during apoptosis in S. domuncula. Both 
effector limbs, grazing of the gastropod and the caspase-dependent apoptosis pathway, led to the 
removal of the apoptotic tissue. Temporarily delayed, the expression of the ASABF gene encoding the 
functionally active peptide occurred, a process that resulted in the elimination of the gastropods. The 
data summarized show that in the sponge system the evolutionary most ancient ASABF peptide is 
involved not only in the microbicidal defense but also in the elimination of eukaryotic invaders. Both 
functions contribute to the rich arsenal of the innate immunity in the most basal metazoan phylum.  
2. Results and Discussion 
2.1. Sponge (S. domuncula, L. baicalensis) ASABF Peptide: Sequence Analysis and Phylogenetic 
Relationships 
By the technique of differential display of transcripts, in total RNA from a field specimen of   
S. domuncula 32 fragments were identified that were strongly upregulated, compared to the RNA from 
a specimen kept in the aquarium. After finding by this technique, the corresponding ESTs were also 
identified in the sponge database [17]. Then the cDNAs were completed. Blast similarity search of the 
deduced polypeptides revealed that two of those sequences shared highest sequence relationship with 
the A. suum ASABF-γ peptide from (BAC00498.1; [23]), and that the sequence from S. domuncula 
was complete; Figure 1A. Therefore, the sponge sequence was termed ASABF peptide Mar. Drugs 2011, 9                                                  
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(ASABF_SUBDO), deduced from the SDASABF cDNA. The similarity/identity score of the deduced 
peptide was 36%/27%. The open reading frame (ORF) of the 467 nt long cDNA ranges from nt47-49 to 
nt296-293(stop) and comprises 83 aa contributing to a theoretical size of 9029 Da and an isoelectric point 
(pI) of 9.28. The peptide possesses one distinct signal sequence at the N-terminal end from aa1 to aa19 
(SignalP 3.0 Server; Technical University of Denmark); Figure 1A. The length of this segment is 
identical to that predicted for the A. suum ASABF-γ peptide [23]; taking this sequence as reference, the 
predicted mature region starts at aa20 and ranges to the C-terminus. Hence, the theoretical   
Mw (molecular weight) is 7026, and the corresponding pI is 9.24. Therefore, the S. domuncula ASABF 
is a cationic protein, with a pI almost identical to that calculated for the mature ASABF from A. suum 
with 8.9 [23]. The S. domuncula ASABF sequence shows the characteristic consensus of the nematode 
CSαβ motif reading C-X(3,18)-C-X(3)-C-X(7,9)-[GS]-X-CX(4-13)-CXC [14].  Like the nematode 
peptide the mature S. domuncula ASABF sequence includes 8 Cys moieties (aa23, aa30, aa34, aa39, aa44, 
aa49, aa51, aa54) that allow the formation of disulfide bridges as highlighted in Figure 1A, and as 
predicted [21]. Secondary structure prediction was performed according to Cole et al. [26]. The 
characteristic CSαβ (cysteine-stabilized α-helix and β-sheet) structural motif [14] has been predicted 
according to Chou and Fasman [27]; Figure 1A. The N-terminal α-helix includes the first two Cys 
residues while the second β-strand comprises the last two Cys residues. No other domain could be 
identified in the sponge peptide [28].  
The complete cDNA (LBASABFr), encoding the L. baicalensis ASABF-related peptide 
(ASABFr_LUBAI), has a length of 558 nts and an ORF spanning the segment nt27-29 to nt321-323(stop), 
predicting a 98 aa moieties long peptide. The theoretical Mw is 10,665 and the pI was predicted with 
7.61. Based on comparisons the signal peptide ranges from aa1 to aa22, followed by the mature peptide 
with an Mw of 8,172 and a theoretical pI of 7.86. This only slightly cationic predicted peptide has only 
4 Cys residues.  
In order to estimate the phylogenetic relationship of the sponge peptides to other metazoan 
sequences, for the alignment the highest related A. suum, Caenorhabditis remanei, Caenorhabditis 
briggsae, and the C. elegans sequences of the ASABF family, as well as the ASABF-related sequence 
from the seahorse Hippocampus kuda have been chosen [29]; additionally the two human defensins 
(the beta defensin-2 and the neutrophil alpha defensin-3 preproprotein) and the only metazoan theta 
defensin (from Papio anubis) were selected. The phylogenetic tree was established by using the plant 
ASABF-related putative defensin AMP1 protein from Arabidopsis thaliana as outgroup. The 
construction of the tree revealed that the ASABF sequences cluster together, including the sponge 
peptide (ASABF from S. domuncula) which forms the basis for that branch (Figure 1B). Separated 
from them are the human and baboon defensins. Interesting is the finding that the L. baicalensis 
ASABF-related peptide clusters together with the defensins that comprise likewise less Cys moieties in 
their mature peptide [23].  Mar. Drugs 2011, 9                                                  
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Figure 1. The S. domuncula ASABF peptide (ASABF_SUBDO), deduced from its cDNA 
(SDASABF). (A) The deduced protein was aligned with the most related sequence from the 
database, the ASABF-γ peptide from A. suum (ASABFg_ASCSUU; BAC00498.1) and the 
distantly similar sequence, the ASABF-related peptide from the Baikalian sponge   
L. baicalensis (ASABFr_LUBAI). Residues conserved (identical or similar with respect to 
their physico-chemical properties) in all sequences are shown in white on black; those 
which share similarity to at least two residues are in black on grey. The borders of the 
signal peptide and the mature peptide are given. The 8 Cys moieties that are involved in 
disulfide bridge formation are numbered; the connectivities of the Cys are indicated. The 
α-helix and the two β-strands are marked with a black solid bar and two open arrows, 
respectively; (B) These three proteins were compared with the related ASABFs from A. suum: 
ASABF-beta (ASABFb_ASCSUU; BAC00497.1), ASABF-delta (ASABFd_ASCSUU; 
BAC00499.1), ASABF-zeta (ASABFz_ASCSUU; BAC57992.1), ASABF-epsilon 
(ASABFe_ASCSUU; BAC41495.1) and the genuine ASABF (ASABF_ASCSUU; 
BAA11943.1); the ASABF from C. remanei: the CRE_25171/ASABF protein 
(ASABFr_CAERE; XP_003113198.1), the ASABF from C. briggsae: CBR-ABF-2 protein 
(ABF-2_CAEBR; XP_002646276.1), the ASABF from C. elegans: ASABF/abf-2 
(ASABF_CAEEL; NP_491252.1), as well as the ASABF-like antimicrobial protein from 
H. kuda (ASABF_HIPKU; AAX58116.2). In addition, the two human defensins, beta 
defensin-2 (DEFb2_HOMO; AAC69554.1) and the neutrophil defensin-3 preproprotein 
(DEFa3_HOMO; NP_005208.1) as well as the theta defensin precursor from P. anubis 
(DEFtc_PAPAN; NP_001135410.1) were aligned. The plant putative defensin AMP1 
protein from A. thaliana (AMP1_ARATH; AAM45086.1) was used as outgroup to root the 
tree. The scale bar indicates an evolutionary distance of 0.1 aa substitutions per position in 
the sequence. 
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Figure 1. Cont. 
 
2.2. Preparation of Recombinant ASABF 
Recombinant protein was prepared in the yeast Pichia pastoris. This eukaryotic expression system 
allows post-translational modifications such as disulfide bonding, which is required for proper folding 
of defensins. Accordingly, the complete ORF of SDASABF, without the putative signal sequence (i.e., 
aa20 to aa83), was expressed as fusion to a 6xHis tag. Following Ni
2+-NTA metal-affinity purification 
(Figure 2Ab), the recombinant protein (8.0 kDa (minus His tag: 7.1 kDa)) was used for immunization 
of rabbits. Then, specificity of the polyclonal anti-ASABF serum (PoAb-rASABFSUBDO) was 
assessed on Western blots (Figure 2Ba), showing a band at the expected size of the recombinant 
protein. In control experiments, 100 µL of the antibodies were adsorbed to 20 µg of the recombinant 
protein prior to their use. Consequently, no band could be observed on the immunoblots after 
application of these blocked antibodies (Figure 2Bb). 
In a parallel set of experiments, the PoAb was applied to detect S. domuncula ASABF in protein 
extracts of sponge specimens that had been sampled from the sea (Figure 2Bc), or that had been 
cultured in aquaria for 12 months (Figure 2Bd). Thus, following SDS-PAGE and immunoblotting of 
identical protein concentrations, a band was detected with a size corresponding to the processed, 
mature variant of ASABF, lacking the signal sequence (i.e., 7.0 kDa). The band intensity was 
considerably stronger in extracts of field specimens than in those of aquarium specimens.  Mar. Drugs 2011, 9                                                  
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Figure 2. Analysis of recombinant and naturally occurring ASABF by SDS-PAGE.   
(A) P. pastoris cells were transformed with the ASABF cDNA (SDASABF), as described 
under “Experimental Section”. After purification, the recombinant protein was analyzed by 
SDS-PAGE. (a) Size markers (M); (b) Purified recombinant ASABF. After size separation 
the gel was stained by Coomassie brilliant blue; (B) (a and b) Western blot analysis of 
recombinant ASABF. The blot-transferred filters were incubated with (a) untreated   
PoAb-rASABFSUBDO, or (b) with PoAb-rASABFSUBDO adsorbed to rASABF_SUBDO; 
(c and d) Protein extracts from animals (c) sampled from the sea, or (d) kept for over 1 
year in the aquarium were used for gel electrophoresis; 5 µg of protein were applied per slot.  
 
2.3. Microbicidal Assay 
The recombinant ASABF caused strong anti-microbial activity in the in vitro assay system (Table 1). 
Especially strong was the effect towards Gram-positive bacteria (S. aureus, B. subtilis, and M. luteus) 
with minimum inhibitory concentrations (MIC) between 2 and 5 µg/mL, while the activity against 
Gram-negative bacteria (P. aeruginosa and E. coli) was considerably lower with concentrations 
between 12 and 17 µg/mL. Interestingly, ASABF also caused distinct inhibitory effects on growth of 
eukaryotic fungi (C. albicans and A. niger) with MIC concentrations between 9 and 13 µg/mL. In 
order to prove that the effect measured was specific, the microorganisms were exposed to recombinant 
ASABF that had been adsorbed with antibodies prior to the addition to the cultures; such samples were 
found to be inhibitory only at MIC above 20 µg/mL.  Mar. Drugs 2011, 9                                                  
 
 
1976
Table 1. Antimicrobial activity of non-adsorbed or antibody-adsorbed recombinant 
ASABF against Gram-positive bacteria, Gram-negative bacteria and two fungi. The 
inhibition is given as minimum inhibitory concentrations (MIC) value in µg/mL. 
Microorganism 
Antimicrobial activity MIC (µg/mL) 
Non-Adsorbed ASABF  Adsorbed ASABF 
Gram-positive bacteria:  Staphylococcus aureus  1.7 ± 0.5  >20 
  Bacillus subtilis  4.8 ± 0.6  >20 
  Micrococcus luteus  3.6 ± 1.0  >20 
Gram-negative bacteria:  Pseudomonas aeruginosa  12.4 ± 5.5  >20 
  Escherichia coli  17.4 ± 6.0  >20 
Fungi:  Candida albicans  8.5 ± 4.0  >20 
  Aspergillus niger  12.9 ± 4.0  >20 
2.4. Hemolytic Activity 
As a convenient assay to study hemolysis human erythrocytes have been used and exposed to 
recombinant ASABF. The cells were exposed to the peptide and the percentage of the lysed 
erythrocytes was determined on the basis of the released hemoglobin. Under the assay conditions 
described under “Experimental Section” it was seen that the recombinant, non-adsorbed ASABF 
caused at a concentration of about 1 µg/mL 35% hemolysis. The degree of lysis increased to 76% at a 
concentration of 10 µg/mL (Figure 3). As a control, the ASABF peptide was adsorbed to anti-ASABF 
serum (PoAb-rASABFSUBDO), as described under “Experimental Section”. Using this ASABF 
sample the degree of lysis was very low and amounted to about 10% at the high concentration of  
10 µg/mL. 
Figure 3. Hemolytic activity of ASABF, assayed in the human erythrocyte lysis assay. Red 
blood cells were incubated for 1 h (37 °C) at increasing concentrations of recombinant 
ASABF (■). In a parallel series of experiments the recombinant ASABF was 
adsorbed to anti-ASABF antiserum (PoAb-rASABFSUBDO) (- - ● - -). Subsequently, the 
lysed erythrocytes were determined on the basis of the released hemoglobin. The values 
represent the means ± SEM of ten experiments each. 
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2.5. Induction of Apoptosis in S. domuncula after Exposure of the Animals to Dip 
If sponge specimens were kept in aquaria at lower aeration rate or in the presence of Fe
++ chelator 
Dip the animals started to develop apoptotic spots/areas on their surface, as described [24]. Those 
regions were initially (after 1 day) marked by a deeper-red color. At a later stage the apoptotic surface 
regions became unstructured to meander-like. Previously, those regions had been identified to undergo 
apoptosis, as had been proven by the “Cell Death Detection ELISA test system” [24]. At day 2 these 
apoptotic regions were colonized by the gastropod Bittium sp. that had been attracted by quinolinic 
acid, a metabolite that is formed after induction of the 3-hydroxyanthranilate 3,4-dioxygenase (HAD) 
gene [24]. At days 2 to 3 the specimens of Bittium sp. (1 to 6 per 5 mm
2) grazed on the apoptotic areas 
(Figure 4A); no gastropods were seen on non-apoptotic surfaces (not shown). As observed before, the 
gastropods ate (Figure 4B,C) and, by that, removed the apoptotic tissue (Figure 4D). After day 7 the 
previously apoptotic regions had been removed.  
Figure 4. Colonialization of S. domuncula specimens by the gastropod Bittium sp. 
Specimens were kept in seawater in the presence of the chelator Dip. After 1 to 2 days in 
the aquarium the surfaces of the specimens developed speckled-type darker-colored areas 
which became apoptotic. (A) In an earlier stage one and soon after up to six gastropods 
colonized those apoptotic areas (> <); (B and C) Grazing gastropods on apoptotic   
areas (double-headed arrows); resulting in (D) a removal of those apoptotic areas   
(double-headed arrow). 
 
2.6. Expression of the ASABF Gene in S. domuncula Specimens: in Situ Hybridization  
Samples from a control specimen and from an animal kept for 1 day in Dip were analyzed by in situ 
hybridization. Using the DIG-labeled anti-sense ssDNA (SDASABF) probe the extent of reaction to the 
tissue structures was low in control sections (Figure 5A,B). In contrast, the reaction of the labeled 
probe with tissue slices from Dip-exposed animals was intense (Figure 5D,E); at a higher 
magnification the reaction with cell structures was evident (Figure 5F). One control was performed by 
hybridizing a sample from the Dip-treated animal with a labeled sense ssDNA probe; there, only 
background signals were recorded (Figure 5C).  Mar. Drugs 2011, 9                                                  
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Figure 5. Expression studies of ASABF gene by application of the in situ hybridization 
technique. (A,B) Control sponge tissue of non-treated sponge specimens or (C–F) from 
animals kept for 1 day in the presence of the chelator Dip and subsequently for an 
additional 1 day in the absence of the chemical, was sliced and the sections were analyzed 
for the expression of the ASABF gene using the SDASABF DIG-labeled probe. In (A,B,D–F) 
hybridization was performed with the anti-sense ssDNA probe; (C) had been hybridized 
with the labeled sense probe. All size bars represent 100 µm.  
 
2.7. Expressions of the HAD, the ASABF as well as the Caspase Genes: Determination by qRT-PCR  
Tissue samples from apoptotic areas on the surface of Dip-treated animals, as well as from control 
animals were taken and subjected to qRT-PCR analysis. For a quantitative assessment steady-state 
gene expressions of HAD (marker for quinolinic acid synthesis), the caspase (formation of apoptotic 
tissue [30]) as well as of ASABF (ASABF synthesis) were chosen. The tissue samples for the 
determination of the respective transcript levels in apoptotic areas were taken from the rim region of 
those regions. The determinations were performed at the beginning of the exposure (day 0), as well as 
after 1 to 9 days. The results showed that the expression level of HAD at the beginning of the 
experiments was approximately 2.1 × 10
−3 with respect to the expression of the house-keeping gene 
tubulin (Table 2). While in the controls the expression level did not significantly change during the 9-day 
incubation period, a strong increase in the steady-state expression of HAD was measured in the   
Dip-treated animals. The maximum of expression was seen already at day 2 (27.1 × 10
−3); during the 
end of the experiment (after 9 days) the expression level returned to normal (3.1 × 10
−3). Focusing on 
ASABF expression, likewise no change of the steady-state expression was observed in the controls 
(around 1.3 × 10
−2). In the Dip-treated specimens a strong and significant increase was found already 
after day 1 (2.8 × 10
−2), while the maximum was seen 4 days after exposure to Dip (9.8 × 10
−2). 
Subsequently, the level of expression decreased. Finally, the expression of the caspase gene likewise 
increased in the Dip-treated animals from 1.5 × 10
−4 (day 0) to 12.4 × 10
−4 at day 3 (Table 2). In the 
control tissue no significant changes were measured. A diagrammatic sketch, summarizing the 
expression levels in apoptotic tissue from the surface of Dip-treated specimens, as well as from Mar. Drugs 2011, 9                                                  
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controls, is given in Figure 6. There, also the surface texture of a 3-day-old apoptotic area with a grazing 
gastropod is shown with its uneven appearance in contrast to the smooth/plain surface in the control. 
Table 2. Expression levels of S. domuncula HAD, ASABF as well as of the caspase genes 
on the surfaces of control animals, not treated with the Fe
++ chelator, or treated with Dip as 
described under “Experimental Section”. Tissue samples from the Dip-treated animals 
were taken from the rim of apoptotic region, or after day 5, from the area which previously 
had been apoptotic and was then cleaned by the gastropod. Then, RNA was extracted and 
expression levels were quantified through qRT-PCR. Each data point represents the mRNA 
level of the respective expressed gene (x: HAD, ASABF or caspase) normalized to the 
amount of β-tubulin transcripts, as means ± SEM (n = five experiments per time point). 
Time 
point 
(days) 
Gene expression: (mRNAx ± SEM)/mRNAtubulin 
HAD ASABF  Caspase 
Control 
(×10
−3) 
Dip-Treated 
(×10
−3) 
Control 
(×10
−2) 
Dip-Treated 
(×10
−2) 
Control 
(×10
−4) 
Dip-Treated 
(×10
−4) 
0  2.1 ± 0.3  2.2 ± 0.3  1.3 ± 0.2  1.3 ± 0.2  1.3 ± 0.1  1.5 ± 0.2 
1  2.3 ± 0.3  5.3 ± 0.6  0.9 ± 0.1  2.8 ± 0.3  1.6 ± 0.2  6.7 ± 0.7 
2  2.4 ± 0.4  27.1 ± 3.8  1.2 ± 0.2  4.0 ± 0.5  1.9 ± 0.2  9.3 ± 1.0 
3  1.9 ± 0.2  19.9 ± 1.7  1.7 ± 0.2  6.3 ± 0.8  1.8 ± 0.1  12.4 ± 1.7 
4  1.9 ± 0.2  7.2 ± 0.9  1.6 ± 0.2  9.8 ± 0.9  1.4 ± 0.3  6.9 ± 0.8 
5  2.2 ± 0.5  4.2 ± 0.6  2.1 ± 0.3  6.9 ± 0.7  1.8 ± 0.2  1.7 ± 0.1 
7  2.3 ± 0.3  3.4 ± 0.4  1.9 ± 0.4  3.7 ± 0.5  1.8 ± 0.2  1.5 ± 0.2 
9  2.5 ± 0.4  3.1 ± 0.3  1.8 ± 0.2  4.4 ± 0.5  2.1 ± 0.3  1.9 ± 0.3 
Figure 6. Diagrammatic sketch of the expression levels of HAD, ASABF as well as of the 
caspase gene in Dip-treated and in control specimens (left). The widths of the bars 
symbolize the level of expression. At the upper right an image of the surface of a 3-day-old 
apoptotic area (double-headed arrow) with a gastropod is shown; lower right shows the 
plain surface of a non-treated specimen. 
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For the expression studies in the above described series of experiments tissue from the rim regions 
had been selected. To obtain a more detailed view of the expression levels of HAD, ASABF and 
caspase tissue samples were taken from within the apoptotic area. Such a spatially resolved study was 
only possible after a more progressed stage of apoptosis, 3 days after Dip exposure. In comparison, tissue 
samples from apoptotic regions after their ablation through the gastropods were analyzed (Figure 7). 
The data revealed that at day 3 the increase in the steady-state level of expression of the HAD gene and 
the ASABF gene was 4.8-fold and 5.9-fold, respectively, while the increase of the expression level for 
the caspase gene was much higher with 12.2-fold.  
Figure 7. Spatially resolved analysis of the expression level of HAD, ASABF as well as of 
the  caspase gene. Tissue samples from controls as well as samples from within the 
apoptotic areas (the diameter of the area is given by a double-headed arrow) of Dip-treated 
specimens were analyzed. The expression is given in arbitrary units as multiple-fold of the 
transcript levels seen in the controls (non-treated animals; day 0). The analyses were 
performed by qRT-PCR 3 days and 8 days after exposure of the specimens to Dip using the 
expression of the tubulin gene as a reference house-keeping gene; the controls remained 
untreated. The means ± SEM (n = 5) are given. 
 
2.8. Acute/Subchronic Toxicity Testing of the Gastropod 
The above outlined results indicate that the drop of the HAD expression coincided (after about 4 
days after exposure to Dip) with the maximum of the expression of the ASABF gene, encoding the 
antimicrobial peptide (Figure 6). In addition, it is seen that after about 5 days the gastropods 
disappeared from the previously apoptotic areas. The reason for the elimination of the gastropods is 
not quinolinic acid, since this dicarboxylic acid is not toxic for those epibionts. Therefore, it was Mar. Drugs 2011, 9                                                  
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intriguing to check if it was the ASABF peptide which may have caused a toxic effect. Accordingly it 
was necessary to test if the recombinant peptide affected the viability of the gastropods.  
As outlined in the assay conditions described under “Experimental Section”, the gastropods were 
exposed for 96 h to ASABF in a serial concentration range. After incubation the mortality in the assays 
with ASABF were determined to be; at 3 µg/mL: 3.5 ± 2%, 10 µg/mL: 26.4 ± 8% and 30 µg/mL:  
75.7 ± 12%. In the controls (untreated animals) 100% of the animals survived. According to the 
standards the toxicity of the ASABF towards the gastropods should be assessed as “highly toxic” (US 
EPA 2011); Figure 8. 
Figure 8. Acute/subchronic toxicity of recombinant ASABF peptide on the gastropod 
Bittium sp. The gastropods were incubated for 4 days with the recombinant peptide. 
Subsequently cultivation of the animals continued for 4 days in seawater without the 
peptide; the mortality was determined as described under “Experimental Section”. 
 
3. Discussion 
Antimicrobial agents that usually represent peptides with a length of less than 50 amino acid 
residues are potent effector molecules of the innate immune system. They interact with both microbial 
and eukaryotic cell membranes and, in turn, cause cell lysis. Besides direct interactions with 
biomembranes, they function in vertebrates also as mediators of inflammation, cause cytokine release, 
affect cell proliferation, and interfere with angiogenesis, wound healing, or chemotaxis [31,32]. Most 
of those peptides are classified to the group of cationic peptides [33], comprising characteristic 
domains, e.g., the cysteine-rich CSαβ-type motif [14]. Already 20 years ago it had been proposed that 
those “antimicrobial peptides” act not only on cell membranes but also affect intracellular targets, as 
has been shown e.g., for the small tachyplesin peptides from horseshoe crabs [34]. The remarkable 
feature of those antimicrobial peptides is their property to act in a broad spectrum against   
Gram-positive and Gram-negative bacteria as well as fungi [35].  
Even though it is known that sponges are rich sources of bioactive compounds of low molecular 
weight [3], no screening for genes encoding antimicrobial peptides from the sponges themselves has 
yet been reported. Unlike the antibiotic peptides, synthesized by the sponge symbionts and encoded by 
them, e.g., by synthases [36], the amino acid sequences of the antimicrobial peptides are encoded by 
the host organism, the sponge itself. Hence, such antimicrobial peptides can be considered to be Mar. Drugs 2011, 9                                                  
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components of the metazoan innate or natural immune system which protects them against prokaryotic 
and eukaryotic invading organisms. The present contribution reports on a gene from S. domuncula, 
encoding an ASABF-type antimicrobial peptide that acts against microorganisms as well as against 
eukaryotic cells. The S. domuncula ASABF is a cationic peptide that comprises eight cysteines 
allowing the formation of four intramolecular disulfide bridges. From the ORF of the full-length 
cDNA sequence an 83-residue precursor peptide can be predicted. From this polypeptide a signal 
peptide of 19 amino acids in length is cleaved off, converting the precursor into a 64 aa long, mature 
peptide. The four disulfide bridges follow the prediction based on the nematode ASABFs [21]. The 
sequence also shares the CSαβ motif with the nematode ASABFs. The sponge polypeptide is, like the 
other ASABFs, related to the defensins which comprise 3-4 intramolecular disulfide bridges [22]. The 
phylogenetic analysis likewise indicated a separation of the ASABFs, including the sponge sequence, 
from the defensins, regardless of whether they come from vertebrates or invertebrates. Like the 
ASABFs the defensins are key elements of the immune system and provide a broad-range defense 
against eukaryotic and protozoan pathogens [16]. It is important to mention that in metazoans the 
defensins are expressed cell-type/tissue specifically and often show modulatory effects on immune 
cells, e.g., macrophages, lymphocytes or mast cells [37]. Even more, an interference of the defensins 
with host cell recognition proteins has been described [38]. These findings on the sequence and 
function polymorphism of the ASABFs/defensins underscore their important role in the innate immune 
system of metazoans.  
The sponge ASABF has been successfully expressed in the P. pastoris system and the biologically 
active peptide was obtained. The recombinant peptide turned out to be highly active against Gram-positive 
bacteria with a MIC concentration between 2 and 5 µg/mL (0.3 to 0.7 µM), and is, hence, similarly 
active as the antimicrobial nematode ASABF peptides, abf-1 and abf-2 [19]. Less effective is the 
sponge peptide against Gram-negative bacteria with >12 µg/mL. In addition, microbicidal activity was 
seen in eukaryotic fungal systems (C. albicans and A. niger) with an inhibitory activity at 9–13 µg/mL. 
Considering the screening range of Zhang et al. [39] we also tested the sponge peptide in the human 
hemolysis system with erythrocytes. Interestingly, even at the low concentration of 1 µg/mL (0.15 µM) 
the sponge peptide caused a significant hemolytic activity; about 30–40% of the erythrocytes were 
found to be lysed at that concentration. This efficiency is considerably higher than that known for the 
nematode A. suum ASABFs [39], which varies around a MIC of 10–30 µg/mL. 
The potent hemolytic activity prompted us to determine the effect of the recombinant sponge 
ASABF on the gastropod Bittium sp. an eukaryotic epibiont that occasionally grazes on S. domuncula. 
Consequently we had to answer two questions. First, the determination of the gene expression status of 
ASABF in a control region and in the areas where the gastropod settled, and second, of the potential 
toxic effect of the recombinant ASABF peptide on the gastropod directly. Previously it had been 
shown that this gastropod settles on the surface of S. domuncula after induction of apoptosis in 
response to a lower oxygen partial pressure [24]. In this previous report apoptosis was measured with 
the “Cell Death Detection ELISA test system” [40] that bases on the quantification of the degree of 
chromatin fragmentation to mono- and oligonucleosomes. During the process of apoptosis the 
expression of the gene for the key enzyme of the quinolinic acid pathway is induced, the   
3-hydroxyanthranilate 3,4-dioxygenase (HAD) that converts 3-hydroxyanthranilate to 2-amino-3-
carboxymuconate 6-semialdehyde under consumption of oxygen. Since the latter metabolite is not Mar. Drugs 2011, 9                                                  
 
 
1983
stable, it non-enzymatically converts to quinolinic acid [41]. This dicarboxylic acid is not only in 
sponges [24] but also in human cells a selective inducer of apoptosis [42]. In sponges the initiating 
enzyme, HAD, is rapidly induced during 2 days after impairing the environment of the animals. After 
formation of quinolinic acid in the apoptotic tissue, the gastropod Bittium sp. colonizes that region, 
very likely attracted by the dicarboxylic acid. Subsequently, as implicated [24], the gastropods ablate 
the apoptotic tissue during a period of 2–3 days. In parallel with the induction of HAD, a significant 
upregulation of the steady-state expression of caspase occurs. Increased transcript levels of caspase in 
apoptotic tissue are also known from earlier studies [30]. After a lag period of 2 days after the 
induction of HAD, the gene encoding the ASABF peptide is induced in the tissue, surrounding the 
apoptotic area. The expression of ASABF in apoptotic tissue is low, almost not existing, while it is 
reasonably expressed in control, non-apoptotic tissue (data not shown). However, if samples are taken 
from regions bordering the apoptotic area that has been eliminated by the gastropods, a strong 
upregulation is seen. The induction of the gene for the ASABF peptide has been described previously 
in the nematode A. suum, after exposure of the worm to heat-killed bacteria [23].  
The toxicity of the ASABF peptide on the gastropod Bittium sp. has been determined under 
controlled, closed conditions. Our toxicity studies revealed that ASABF is already lethal for the 
animals at a concentration of the recombinant peptide as low as 10–30 µg/mL during an incubation 
period of 4 days. This first description of an antimicrobial peptide from sponges which is toxic for 
animal cells and is likely used as a defense against attacking predators, widens the view of the activity 
spectra of the “antimicrobial” peptides. Consequently, the sponge ASABF, a member of the innate 
immune system, most likely acts as a broad-spectrum defense molecule. The perhaps ubiquitous 
presence of antimicrobial peptides of the ASABF type in sponges is supported by the identification of 
the ASABF-related gene in the freshwater sponge L. baicalensis.  
4. Experimental Section 
4.1. Chemicals, Materials and Enzymes 
The sources of the materials used for this study were given previously [43]. In addition, Dip   
(2,2'-dipyridyl) was purchased from Sigma/Aldrich (St. Louis, MO; USA), and PCR DIG (digoxigenin) 
Probe Synthesis Kit, anti-DIG AP Fab fragments, as well as disodium 2-chloro-5-(4-methoxyspiro 
{1,2-dioxetane-3,2′-(5′-chloro)tricyclo[3.3.1.1
3,7]decan}-4-yl)-1-phenyl phosphate (CDP-Star) were 
obtained from Roche (Mannheim; Germany). 
4.2. Sponges and Gastropod/Mollusc Colonization 
Specimens of the marine sponge S. domuncula (Porifera, Demospongiae, Hadromerida) were 
sampled in the Northern Adriatic near Rovinj (Croatia), and then kept in aquaria in Mainz (Germany) 
at a temperature of 17 °C for more than 12 months. Extracts were prepared from tissue samples by 
treatment with four parts of a 0.4 M Tris-HCl buffer (pH 8.0; supplemented with 50 mM NaCl,   
0.5 mM EDTA and 5 mM MgCl2). After grinding, and stirring of the suspension at 2 °C for 1 h a clear 
supernatant was obtained after centrifugation (20,000 × g, 30 min, 2 °C); this was collected and Mar. Drugs 2011, 9                                                  
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contained between 3 and 7 mg of protein per mL. This extract was diluted down to 2 mg/mL and used 
for the experiments.  
The experiments were performed in 5 L (artificial sea water [24]) aquaria, containing 3 sponges 
each. Apoptosis was induced in sponges by keeping the specimens in the presence of 50 µg/mL of the 
Fe
++ chelator Dip [44] for 1 day. Under these conditions the specimens responded with the formation 
of speckled patches on their surfaces, as described earlier [24]. By application of the “Cell Death 
Detection ELISA test system” (Roche) apoptosis was proven in these regions [24]. To each aquarium, 
both controls and Dip (2,2'-dipyridyl) supplemented ones, approximately 100 specimens of the 
gastropod/mollusc Bittium sp. (Mollusca, Gastropoda, Cerithiidae, Bittium) were added. Already 1 day 
later the apoptotic patches on the sponge surfaces were covered by 1 to 6 specimens of Bittium sp. per 
5 mm
2 (Dip-treated), while on the surfaces of specimens kept in absence of Dip (controls) no 
gastropods were seen. As described before, the gastropods ablated the apoptotic tissue within 3 days. 
Seven days after the beginning of the experiments no signs of apoptotic tissue could be seen. Tissue 
samples were taken at the beginning of the experiments as well as after 1 day, 2 days, 3 days, 4 days,  
5 days, 7/8 days, and 9 days from Dip-treated (speckled-type regions) and from control regions, and 
analyzed for gene expression.  
4.3. Maintenance of the Gastropod Bittium sp. 
Bittium sp. (Gastropoda: Cerithiidae) are common grazers, epizoons [45], abundantly seen on the 
surfaces of S. domuncula apoptotic specimens. The gastropods were collected, transferred to nets 
(mesh size 44 µm) and could be kept in aquaria, for over 30 days, without losing more than 10% of the 
specimens. Routinely, the gastropods were used for the experiments 6 days after collection from the 
apoptotic specimens.  
4.4. Identification and Cloning of the Poriferan ASABF Peptides 
S. domuncula ASABF: For the identification of the cDNAs encoding putative defensin-like 
molecules the technique of differential display was employed according to Müller et al. [4]. Total 
RNA was extracted from S. domuncula specimens that had been sampled from the sea or had been 
cultivated in aquaria for more than one year. Specimens that had been taken from nature showed a 
higher load of bacteria and, in turn, were more likely to express those polypeptides in a wider array of 
antibacterial defense molecules and at higher expression levels than aquarium animals [46]. The 
cloning procedure, given in details before [4] is outlined in brief: 1.8 µg of total RNA of aquarium 
animals or of field specimens was reverse transcribed using the anchored oligo(dT) primer T11CC and 
SuperScript III Reverse Transcriptase (Invitrogen, Darmstadt; Germany). Following first-strand cDNA 
synthesis, the samples were diluted 1:10 with H2O and, then, subjected to polymerase chain reaction 
(PCR). For this reaction, Platinum Taq DNA polymerase (Invitrogen) was employed in combination 
with the IR-labeled arbitrary primer 5′-GTGATCGCAG-3′ and an oligo(dT) primer. After initial 
denaturation at 94 °C for 2 min, cDNA was amplified during 38 cycles each, at 94 °C for 30 s, 42 °C 
for 120 s, and 72 °C for 30 s, followed by a final incubation of 10 min at 72 °C. Subsequently, 
amplicons were size-separated during polyacrylamide gel electrophoresis, using an automated DNA 
sequencer (LI-COR 4300 DNA Analysis System). Then, cDNAs between 250 and 400 nucleotides (nt) Mar. Drugs 2011, 9                                                  
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of differentially expressed transcripts were excised using the Odyssey (LI-COR) infrared imaging 
system and subsequently reamplified by PCR. Finally, the products were sub-cloned in the pGEM-T 
vector (Promega) and sequenced. Complete cDNAs were obtained by primer walking [47]. Thus, the 
clone  SDASABF was identified (among 32 differentially expressed transcripts found within field 
animals), comprising 467 nts (excluding the poly(A) tail) with an ORF encoding the putative protein 
ASABF_SUBDO. 
L. baicalensis ASABF: Following the identification of S. domuncula ASABF, >2500 L. baicalensis 
ESTs [28] were screened for related sequences. One clone was discovered, comprising 558 nts with 
considerable sequence homology to SDASABF, which was termed LBASABFr. The ORF was found to 
be complete.  
4.5. Sequence Analyses 
Homology searches were conducted through servers at the European Bioinformatics Institute, 
Hinxton, United Kingdom and the National Center for Biotechnology Information (NCBI), Bethesda, 
MD [29]. Multiple alignments were carried out with ClustalW version 1.6 [48]. Phylogenetic trees 
were constructed on the basis of aa sequence alignments applying the Neighbor-Joining method to 
distance matrices that were calculated using the Dayhoff PAM matrix model [49,50]. The degree of 
support for internal branches was further assessed by bootstrapping [51]. The graphical output of the 
bootstrap figures was produced through the “Treeview” software [52] and GeneDoc [53]. Potential 
domains, subunits, patterns, and transmembrane regions were predicted searching the Pfam [54] or the 
SMART database [55]. 
4.6. Preparation of Recombinant S. domuncula ASABF Peptide 
cDNA of S. domuncula ASABF, coding for the complete mature protein (aa20 to aa83), was cloned 
as gene of interest into the pPIC3.5 yeast expression vector (Invitrogen) via SnaB I and EcoR I. At the 
5' terminus, an ATG initiation codon was placed within the context of a yeast translation initiation 
sequence ([56] and according to the manufacturer’s protocol). Additionally, the cDNA contained a  
3' 6xhistidine (His) tag coding sequence (to facilitate metal-affinity chromatography purification of the 
recombinant protein), followed by a stop codon. After digestion with Sal I, chemically competent 
Pichia pastoris GS115 cells were transformed with the linearized construct. Subsequently, 
transformants were selected for their ability to grow on histidine-deficient medium. For recombinant 
protein expression, transformants were cultured for 84–96 h at 30 °C in appropriate medium with 0.5% 
(v/v) methanol. Then, cells were harvested, transferred into Breaking Buffer (50 mM sodium 
phosphate pH 7.4, 1 mM PMSF (phenylmethylsulfonyl fluoride), 1 mM EDTA, 5% glycerol), and 
homogenized (Precellys; PeqLab, Erlangen; Germany). Finally, the recombinant protein (termed 
rASABF_SUBDO) was purified through nickel-nitrilotriacetic acid (Ni
2+-NTA) metal-affinity 
chromatography and checked through SDS-PAGE.  Mar. Drugs 2011, 9                                                  
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4.7. Preparation of Antibodies 
The purified, recombinant ASABF protein (rASABF_SUBDO) was used for the production of 
polyclonal antibodies (PoAb), as described [8,57]. Thus, female rabbits (White New Zealand) were 
immunized thrice with 20 μg/boost. Following collection of the PoAb (termed PoAb-rASABFSUBDO) 
the titer was determined to be 1:5,000. For control experiments, 100 µL of PoAb were incubated with 
20 µg of the antigen during an incubation period of 1 h (4 °C). Only then (adsorbed antibody 
preparation) these blocked antibodies were applied to immunodetection assays.  
4.8. SDS-PAGE and Immunodetection Analysis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was routinely performed 
as follows. Samples of 6 μg of protein were mixed with loading buffer (Roti-Load; Carl Roth, 
Karlsruhe; Germany), boiled for 8 min, and subjected to SDS-PAGE (15% acrylamide and 0.1% SDS) 
as described [58]. The gels were stained with Coomassie brilliant blue. The protein size standard “Dual 
Color” (Carl Roth) was used to estimate protein sizes. For Western blot analyses, size-separated 
proteins were transferred to PVDF-Immobilon membranes. Then, the membranes were blocked at 
room temperature with blocking solution (Roche; 1% (v/v) in TBS-T buffer; 20 mM Tris-HCl pH 7.6, 
137 mM NaCl, 0.1% (v/v) Tween-20). Following consecutive incubations with   
PoAb-rASABFSUBDO (1:3,000 dilution in TBS-T, supplemented with 0.1% (v/v) Blocking solution), 
alkaline phosphatase (AP)-conjugated species-specific secondary antibodies (1:4000 dilution), and   
4-nitro blue tetrazolium chloride (NBT)/5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Invitrogen), 
proteins were detected colorimetrically. The “Ultra-Low Range Marker” (Sigma; M3546) was used to 
determine the apparent size of the peptide.  
4.9. Quantitative Real-Time RT-PCR (qRT-PCR) 
Quantitative real-time RT-PCR (qRT-PCR) was applied to determine the steady-state expression of 
the gene encoding ASABF (SDASABF), as recently described in detail [59,60]. Following extraction of 
tissue RNA was treated with DNAse to eliminate contaminating genomic DNA. First strand cDNA 
synthesis was performed by SuperScript III Reverse Transcriptase in a reaction mixture containing  
5 µg of total RNA, dNTPs, oligo(dT)18, and reverse transcriptase buffer (Invitrogen) at 42 °C for 1 h. 
After enzyme inactivation (65 °C, 15 min), qPCR experiments were performed in an iCycler   
(Bio-Rad), using 1/10 serial dilutions in triplicate as described [61]. After appropriate dilution, 2 µL of 
the reaction mixture were employed as a template for 30 µL qPCR assays. Each reaction contained 
“Absolute Blue SYBR Green” master mixture (ABgene, Hamburg; Germany) and 5 pmol of each 
primer. All reactions were run with an initial denaturation at 95 °C for 3 min, followed by 40 cycles 
each, of 95 °C for 15 s, 62 °C for 30 s, 72 °C for 35 s, and 80 °C for 20 s. The following primers were 
used for amplification of SDASABF: Fwd: 5'-GCAAAGCTGGCAGAGTTGGAT-3' (nt114 to nt134) and 
Rev: 5'-AGATTTTGAACTTGTTGAAAGG-3' (nt245 to nt224); the size of the fragment obtained was 
132 bp. For the amplification of the S. domuncula caspase gene SDCASPL (NCBI accession number 
AM392430.1; [8]) Fwd: 5'-GGACAAACAGATGTACACAGAG-3' (nt597 to nt618) and Rev:   
5'-GATGTAGTTTCCTTCTGGAGGT-3' (nt732 to nt711) were applied, resulting in a fragment   Mar. Drugs 2011, 9                                                  
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of 136 bp. Finally, the expression level of the S. domuncula 3-hydroxyanthranilate 3,4-dioxygenase 
(HAD; AJ298053.1) was quantified using the primer pair Fwd:   
5'-CTCAGGTACTATGTTGATGGTA-3' (nt369 to nt390) and Rev:   
5'-TGGACTTCCATTCTTGTGTTCC-3' (nt300 to nt279); size of the fragment, 132 bp. The expression 
of the house-keeping gene β-tubulin (AJ550806; [62]) was determined with the following primers, 
Fwd: 5'-AACCGCTGTTTGCGACATCC-3' (nt1,126 to nt1,145) and Rev:   
5'-CAATGCAAGAAAGCCTTTCGCC-3' (nt1266 to nt1245); fragment size, 141 bp. The threshold 
position was set to 50.0 RFU above PCR subtracted baseline for all runs. Mean Ct values and 
efficiencies were calculated by the iCycler software. Expression levels of the respective transcripts 
were correlated with the one for  β-tubulin to assess the relative expression levels 
(ETub
CtTub/EASABF
CtASABF; ETub
CtTub/ECasp
CtCasp; ETub
CtTub/EHAD
CtHAD); whereby “E” describes the PCR 
efficiency and “Ct” represents the threshold cycle. 
4.10. In Situ Hybridization 
In situ hybridization assays of S. domuncula tissue slices were performed according to Schröder  
et al. [62]. Briefly, labeling of ssDNA probes (SDASABF) was carried out with the PCR DIG Probe 
Synthesis Kit (Roche), using either forward primer 5'-ATGAATGCAAAGTTGTGCACTC-3' (nt47 to 
nt68; for the sense probe) or reverse primer 5'-CAAGCGCGTTCTTCATCGAC-3' (nt297 to nt278; for 
the anti-sense probe) in combination with a linearized template. The resulting labeled ssDNA probes 
spanned nt47 to nt297 of the SDASABF cDNA. Then, cryosections (8 µm thickness) were fixed with 
paraformaldehyde, washed with PBS (10 mM sodium phosphate pH 7.4, in 150 mM NaCl) at room 
temperature, and incubated with Proteinase K. For rehydration, the sections were hybridized with the 
anti-sense or sense probe (negative control) overnight at 40°C. After blocking, the sections were 
incubated for 1 h at 37 °C with anti-DIG Fab fragments (conjugated to alkaline phosphatase) and, then, 
washed twice. For visualization of the signals, the dye reagents BCIP/NBT (5-bromo-4-chloro-3'-
indolyphosphate/nitro-blue tetrazolium) were used in a Tris-buffer (100 mM Tris-HCl pH 9.5, 100 mM 
NaCl, and 50 mM MgCl2). 
4.11. Microbicidal Assay 
Microbicidal/antibacterial assay was performed as earlier described [63,64] using the Mueller 
Hinton Medium (DIFCO Invitrogen, Karlsruhe; Germany) at pH 7.0. The following microorganisms 
were tested: the Gram-positive bacteria Staphylococcus aureus ATCC 25293, Bacillus subtilis ATCC 
6633, and Micrococcus luteus ATCC 9341, the Gram-negative bacteria Pseudomonas aeruginosa 
ATCC 9027, and Escherichia coli ATCC 25922), and the fungi Candida albicans ATCC 10231 and 
Aspergillus niger ATCC 16404. The minimal inhibitory concentration (MIC) was determined and the 
values were given in µg/mL.  
4.12. Hemolytic Assay 
Human type A erythrocytes were used for the hemolytic assay; they came from healthy individuals. 
The detailed assay has been described earlier [39,65]. PBS-washed erythrocytes were used to prepare a Mar. Drugs 2011, 9                                                  
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10% (v/v) suspension by using an isotonic glucose phosphate buffer (1 mM K-phosphate buffer,   
pH 7.0; supplemented with 287 mM glucose). Serial dilutions of recombinant non-adsorbed or 
adsorbed ASABF were prepared to a final volume of 200 µL in 96-well V-bottomed microtiter plates 
(Nunc/Thermo Electron, Langenselbold; Germany). To reach total hemolysis the samples were 
subjected to 1% (v/v) Triton X-100. After incubation for 1 h (37 °C) the plates were centrifuged  
(10 min at 2000 × g at 20 °C) and a 150 µL aliquot from the supernatant was taken and used for 
absorbance measurements at 450 nm. The percentage of hemolysis was calculated as described [65] 
((A450 of the ASABF-treated sample − A450 of buffer-treated sample)/(A450 of Triton X-100-treated 
sample − A450 of buffer-treated sample)) × 100%.  
4.13. Acute/Subchronic Toxicity Testing 
The gastropods, collected from one affected specimen of S. domuncula, were exposed at 17°C to  
3 µg/mL, 10 µg/mL, or 30 µg/mL of recombinant ASABF in seawater, or remained without this 
peptide. The animals, 10 specimens per assay, were kept in parallel in aerated aquaria (volume of  
200 mL) for 96 h. Subsequently the gastropods were transferred to seawater without the peptide and 
culture continued for 96 more hours. Then the living gastropods were counted. The means ± standard 
deviations of three series of experiments were calculated by using the paired Student’s t-test [66].  
4.14. Further Methods 
For the quantification of protein, the Bradford method ([67]; Roti-Quant solution-Roth) was used.  
5. Conclusion 
In the present study we describe, for the first time, a sponge ASABF peptide and show that the 
polypeptide, deduced from the complete cDNA, comprises the characteristic features of ASABF 
peptides so far identified especially in nematodes. The induction of the ASABF gene was monitored in 
tissue undergoing apoptosis. In those apoptotic regions the expression of ASABF is preceded by the 
expression of HAD, which encodes a key enzyme involved in the formation of quinolinic acid, and in 
parallel by the expression of the caspase gene that initiates and regulates the onset and the completion 
of the apoptotic process. The elimination of the apoptotic tissue is supported by the gastropod Bittium sp. 
which is attracted by the initially synthesized quinolinic acid and finally eliminated by ASABF. In 
parallel to the elimination of the gastropod, also potentially attacking microorganisms are killed by 
ASABF. Our data demonstrate that the innate immune network, based on antimicrobial peptides, in 
sponges is complex and together with the host-encoded immune defense arm, ASABF, involves a 
transient grazing of symbiotic gastropods that accelerate the elimination of apoptotic tissue (Figure 9). Mar. Drugs 2011, 9                                                  
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Figure 9. Schematic outline of the elimination of apoptotic tissue from the sponge   
S. domuncula, after induction with the Fe
++ chelator Dip. Initially the expression of the 
HAD gene is induced as a response to Dip. After initiation of Dip-induced apoptosis the 
caspase gene is upregulated and, sequentially, the expression of the ASABF gene sets on. 
While quinolinic acid, a metabolite synthesized via the HAD/kynurenine pathway, attracts 
the gastropod Bittium sp. the terminally expressed ASABF causes, after removal of the 
apoptotic tissue, an repelling of the gastropods as well as a killing of the microorganisms.  
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